MedTrace Logo

Effects of Chinese Medicine on Patients With Severe Acute Exacerbation of COPD

NCT06455670 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 468

Last updated 2024-10-22

No results posted yet for this study

Summary

The purpose of this study was to evaluate the effects of Chinese Medicine on patients with severe AECOPD, and to provide a basis for the establishment of integrated CM and Western medicine diagnosis and treatment scheme for patients with severe AECOPD.

Conditions

  • Acute Exacerbation Of Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Sanhan Huayin recipe, Qingre Huatan recipe or Zaoshi Huatan recipe

On the basis of conventional treatment of western medicine,the experimental group will be given Sanhan Huayin granule , Qingre Huatan granule or Zaoshi Huatan granule based on CM syndrome differentiation.Take 1 dose daily for 10 days.

DRUG

Sanhan Huayin recipe placebo, Qingre Huatan recipe placebo or Zaoshi Huatan recipe placebo

On the basis of conventional treatment of western medicine, in the experimental group 5% of the placebo drug, color, smell, taste, appearance, weight, similar to the experimental drug, drug packaging and test group. One dose was given daily for 10 days.

Sponsors & Collaborators

  • Peking University Third Hospital

    collaborator OTHER

  • Jiangsu Province Hospital of Traditional Chinese Medicine

    collaborator OTHER

  • Chengdu University of Traditional Chinese Medicine

    collaborator OTHER

  • Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

    collaborator OTHER

  • Shenzhen Hospital of Southern Medical University

    collaborator OTHER

  • Qingdao Haici Hospital

    collaborator OTHER

  • Xiangyang Hospital of Traditional Chinese Medicine

    collaborator UNKNOWN

  • Henan University of Traditional Chinese Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-20
Primary Completion
2027-04-30
Completion
2027-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06455670 on ClinicalTrials.gov